Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20372 | 26005677 | Hepatobiliary Surg Nutr | Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. | 2015 | Details |
| A20376 | 26003897 | Surg Obes Relat Dis | The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. | 2015 | Details |
| A20378 | 26003548 | Obes Surg | Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients. | 2015 | Details |
| A20381 | 26001595 | Transl Res | High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis. | 2015 | Details |
| A20383 | 26000287 | Biomed Res Int | Inhibitory effects of eucalyptus and banaba leaf extracts on nonalcoholic steatohepatitis induced by a high-fructose/high-glucose diet in rats. | 2015 | Details |
| A20384 | 25999863 | Front Physiol | The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. | 2015 | Details |
| A20392 | 25994191 | Eur Radiol | Cost-utility analysis of nonalcoholic steatohepatitis screening. | 2015 | Details |
| A20394 | 25993881 | Expert Rev Gastroenterol Hepatol | Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives. | 2015 | Details |
| A20395 | 25993869 | Eksp Klin Gastroenterol | [Comorbidity of diseases of the liver, biliary tract and psoriasis]. | 2015 | Details |
| A20397 | 25993337 | PLoS One | Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis. | 2015 | Details |
| A20401 | 25991038 | Hepatology | The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20404 | 25988562 | J Pediatr Gastroenterol Nutr | Omega-3 Fatty Acid-Rich Parenteral Nutrition: Is It a Double-Edged Sword? | 2015 | Details |
| A20406 | 25988358 | Atherosclerosis | Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. | 2015 | Details |
| A20417 | 25980762 | J Hepatol | Statin use and non-alcoholic steatohepatitis in at risk individuals. | 2015 | Details |
| A20422 | 25974899 | Semin Liver Dis | Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications. | 2015 | Details |
| A20425 | 25974331 | J Gastroenterol Hepatol | Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects. | 2015 | Details |
| A20428 | 25973647 | J Gastroenterol Hepatol | Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification. | 2015 | Details |
| A20431 | 25971926 | Int J Obes (Lond) | Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice. | 2015 | Details |
| A20436 | 25967348 | Eur J Pharmacol | Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. | 2015 | Details |
| A20440 | 25961735 | PLoS One | Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients. | 2015 | Details |
| A20450 | 25956613 | Hepatol Int | Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20455 | 25951129 | Nutrients | Can skin exposure to sunlight prevent liver inflammation? | 2015 | Details |
| A20456 | 25950913 | PLoS One | A post-developmental genetic screen for zebrafish models of inherited liver disease. | 2015 | Details |
| A20462 | 25947027 | Nihon Shokakibyo Gakkai Zasshi | [Nonalcoholic steatohepatitis after pancreatoduodenectomy with rapid progression of hepatic fibrosis: a case report]. | 2015 | Details |
| A20465 | 25945002 | World J Gastroenterol | Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. | 2015 | Details |
| A20467 | 25941527 | Front Immunol | The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation. | 2015 | Details |
| A20477 | 25937862 | World J Hepatol | Non-alcoholic fatty liver disease: The diagnosis and management. | 2015 | Details |
| A20479 | 25935633 | Gastroenterology | Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20493 | 25923941 | Eur J Gastroenterol Hepatol | Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20505 | 25917981 | Obes Surg | Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology. | 2015 | Details |
| A20506 | 25917783 | Gastroenterology | Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. | 2015 | Details |
| A20507 | 25917329 | FASEB J | Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a. | 2015 | Details |
| A20508 | 25916635 | Biochim Biophys Acta | Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway. | 2015 | Details |
| A20511 | 25915484 | Curr Drug Targets | Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20512 | 25914777 | World J Hepatol | Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. | 2015 | Details |
| A20515 | 25914452 | World J Gastroenterol | Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy. | 2015 | Details |
| A20519 | 25913437 | Aliment Pharmacol Ther | Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States. | 2015 | Details |
| A20531 | 25906757 | J Endocrinol Invest | 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. | 2015 | Details |
| A20536 | 25905490 | PLoS One | Higher estimated net endogenous Acid production may be associated with increased prevalence of nonalcoholic Fatty liver disease in chinese adults in Hong Kong. | 2015 | Details |
| A20544 | 25897647 | Crit Rev Food Sci Nutr | The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
| A20558 | 25887687 | Clin Res Hepatol Gastroenterol | Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis. | 2015 | Details |
| A20559 | 25887357 | Diabetes Care | Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. | 2015 | Details |
| A20560 | 25886887 | BMC Gastroenterol | Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. | 2015 | Details |
| A20564 | 25881230 | BMC Gastroenterol | Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model. | 2015 | Details |
| A20579 | 25875119 | Nutrients | A green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats. | 2015 | Details |
| A20582 | 25873639 | Gut | Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. | 2015 | Details |
| A20583 | 25873207 | Aliment Pharmacol Ther | Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study. | 2015 | Details |
| A20584 | 25873078 | Exp Biol Med (Maywood) | Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. | 2015 | Details |
| A20591 | 25868633 | Dig Dis Sci | Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice. | 2015 | Details |
| A20593 | 25866601 | World J Hepatol | Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. | 2015 | Details |
| A20597 | 25865049 | Gastroenterology | Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20602 | 25863110 | Clin Biochem | Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals. | 2015 | Details |
| A20604 | 25859289 | Clin Epigenetics | Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. | 2015 | Details |
| A20607 | 25854911 | Wien Klin Wochenschr | Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease. | 2015 | Details |
| A20609 | 25852271 | World J Gastroenterol | Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C. | 2015 | Details |
| A20613 | 25850622 | Curr Drug Targets | Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20616 | 25849950 | Nutrients | Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease. | 2015 | Details |
| A20621 | 25848479 | World J Hepatol | Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. | 2015 | Details |
| A20622 | 25848465 | World J Hepatol | Angiogenesis and liver fibrosis. | 2015 | Details |
| A20623 | 25848461 | World J Hepatol | Non-alcoholic fatty liver disease and psoriasis: So far, so near. | 2015 | Details |
| A20638 | 25840922 | Dig Dis Sci | Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology. | 2015 | Details |
| A20639 | 25840592 | Expert Opin Drug Discov | The application of engineered liver tissues for novel drug discovery. | 2015 | Details |
| A20642 | 25838034 | Metabolism | Endoplasmic Reticulum Stress Response in Non-alcoholic Steatohepatitis: The Possible Role of Physical Exercise. | 2015 | Details |
| A20644 | 25836944 | Diabetes Res Clin Pract | Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. | 2015 | Details |
| A20645 | 25835982 | Obes Surg | Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery. | 2015 | Details |
| A20652 | 25830783 | Ann Gastroenterol | Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India. | 2020 | Details |
| A20656 | 25825857 | Clin Obes | Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies. | 2014 | Details |
| A20658 | 25824073 | Clin Med (Lond) | Non-alcoholic fatty liver disease: when to intervene and with what. | 2015 | Details |
| A20662 | 25822435 | J Gastrointestin Liver Dis | Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20666 | 25819147 | Orv Hetil | [Non-invasive assessment of fatty liver]. | 2015 | Details |
| A20670 | 25816330 | PLoS One | Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice. | 2015 | Details |
| A20673 | 25814186 | Pharmacol Res | Effect of resveratrol on experimental non-alcoholic steatohepatitis. | 2015 | Details |
| A20679 | 25805928 | World J Gastroenterol | Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes? | 2015 | Details |
| A20684 | 25801076 | Aliment Pharmacol Ther | PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C. | 2015 | Details |
| A20696 | 25794572 | Curr Treat Options Gastroenterol | New medical treatment strategies for nonalcoholic steatohepatitis. | 2015 | Details |
| A20701 | 25789613 | PLoS One | Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer. | 2015 | Details |
| A20708 | 25788200 | Hepatol Int | Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center. | 2015 | Details |
| A20710 | 25788193 | Hepatol Int | New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan. | 2015 | Details |
| A20711 | 25788185 | Hepatol Int | A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. | 2014 | Details |
| A20715 | 25784075 | Dig Dis Sci | Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function. | 2015 | Details |
| A20720 | 25776890 | J Hepatol | Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20724 | 25775582 | Proc Natl Acad Sci U S A | Immunomodulatory spherical nucleic acids. | 2015 | Details |
| A20726 | 25774446 | Curr Opin Gastroenterol | Nonalcoholic fatty liver disease: new treatments. | 2015 | Details |
| A20727 | 25773826 | Asian Pac J Cancer Prev | Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes. | 2015 | Details |
| A20729 | 25772748 | J Gastroenterol Hepatol | Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery. | 2015 | Details |
| A20732 | 25772036 | J Hepatol | Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). | 2015 | Details |
| A20739 | 25766252 | Sci Rep | Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers. | 2015 | Details |
| A20748 | 25757271 | Yao Xue Xue Bao | [Recent advances in curcumin and its derivatives for treatment of liver diseases]. | 2014 | Details |
| A20758 | 25753407 | Obes Rev | Paediatric non-alcoholic fatty liver disease: an overview. | 2015 | Details |
| A20760 | 25751727 | Int J Mol Sci | Potential epigenetic mechanism in non-alcoholic Fatty liver disease. | 2015 | Details |
| A20770 | 25744849 | Sci Rep | Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis. | 2015 | Details |
| A20773 | 25743002 | Intern Med | Background of the FIB-4 index in Japanese non-alcoholic fatty liver disease. | 2015 | Details |
| A20778 | 25740255 | Nat Commun | Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. | 2015 | Details |
| A20782 | 25737730 | Hepat Mon | The role of interleukin-6 and interleukin-8 gene polymorphisms in non-alcoholic steatohepatitis. | 2014 | Details |
| A20792 | 25732418 | Am J Gastroenterol | Plasma cathepsin D levels: a novel tool to predict pediatric hepatic inflammation. | 2015 | Details |
| A20793 | 25730177 | Curr Opin Gastroenterol | Vibration-controlled transient elastography: a practical approach to the noninvasive assessment of liver fibrosis. | 2015 | Details |
| A20794 | 25729888 | J Pediatr Gastroenterol Nutr | Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20795 | 25729762 | Cell Mol Gastroenterol Hepatol | Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20799 | 25729475 | World J Hepatol | Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. | 2015 | Details |
| A20806 | 25724480 | Mol Cell Endocrinol | Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | 2015 | Details |